NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $622 | -63.6% | 14,991 | -47.2% | 0.00% | 0.0% |
Q1 2023 | $1,707 | +110.7% | 28,401 | +157.0% | 0.00% | -25.0% |
Q4 2022 | $810 | -99.9% | 11,051 | +92.4% | 0.00% | -20.0% |
Q2 2021 | $1,273,000 | +27.2% | 5,743 | -24.2% | 0.01% | +25.0% |
Q1 2021 | $1,001,000 | +0.8% | 7,578 | +31.9% | 0.00% | 0.0% |
Q4 2020 | $993,000 | -47.3% | 5,744 | -79.5% | 0.00% | -60.0% |
Q1 2020 | $1,885,000 | -22.8% | 28,000 | -3.4% | 0.01% | 0.0% |
Q4 2019 | $2,443,000 | -40.6% | 29,000 | -47.3% | 0.01% | +11.1% |
Q3 2019 | $4,112,000 | +171.1% | 55,000 | +129.2% | 0.01% | +28.6% |
Q2 2019 | $1,517,000 | +254.4% | 24,000 | +169.7% | 0.01% | +250.0% |
Q1 2019 | $428,000 | +109.8% | 8,900 | +45.9% | 0.00% | +100.0% |
Q4 2018 | $204,000 | -50.0% | 6,100 | -21.8% | 0.00% | -50.0% |
Q3 2018 | $408,000 | – | 7,800 | – | 0.00% | – |
Q3 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2016 | $16,000 | -20.0% | 1,400 | 0.0% | 0.00% | – |
Q1 2016 | $20,000 | -67.7% | 1,400 | -50.0% | 0.00% | – |
Q4 2015 | $62,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |